Related Experiment Video
Updated: Feb 28, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Special Issue "Genetic Modifiers of Hemoglobinopathies: Recent Advances and Future Directions"
Carsten W Lederer1, Alex E Felice2, Petros Kountouris1
1Blood Disorder Genetics & Thalassemia, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus.
Hemoglobinopathies are genetic blood disorders affecting red blood cells. These conditions exhibit significant variation in symptoms and disease severity, impacting patients differently.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Hemoglobinopathies are monogenic disorders impacting erythrocyte biology.
- These conditions present with high phenotypic diversity, affecting disease phenomena and severity.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Multiple Allele Traits
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics and Pharmacogenomics: Overview

